TWO SIGMA INVESTMENTS, LP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$8,127
-54.8%
21,905
-40.1%
0.00%
Q3 2022$18,000
+50.0%
36,591
+82.6%
0.00%
Q2 2022$12,000
-98.3%
20,035
-96.3%
0.00%
-100.0%
Q4 2021$716,000
+400.7%
542,212
+2654.7%
0.00%
Q1 2021$143,000
-64.8%
19,683
-79.0%
0.00%
-100.0%
Q4 2020$406,000
-7.1%
93,932
+29.1%
0.00%
-50.0%
Q2 2020$437,000
+9.5%
72,752
+37.2%
0.00%
-33.3%
Q1 2020$399,000
+33.9%
53,015
+144.5%
0.00%
+200.0%
Q4 2019$298,00021,6870.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders